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Abstract 
Glycogen is the main storage unit of glucose and is found in tissues throughout the body. 
Tissue development and the contribution from glycogen in the fetal mouse can be followed by 
measuring glycogen concentrations in fetal tissues. In the present work, glycogen concentrations 
in the brain, heart, lung, liver, and muscle of wild-type fetal mice are compared from 14.5 to 18.5 
dpc. The results indicate that glycogen level reaches a maximum at 16.5 dpc in the brain and 
muscle, 15.5 dpc in the heart, 18.5 dpc in the liver, and 17.5 dpc in the lung. 
Introduction 
Glycogen, a branched polymer of glucose, is a storage form of carbohydrate and is 
present in almost all organisms (Pederson, 4, 6, 9, 12). Insulin induces the uptake of glucose into 
some tissues, and its subsequent conversion to glycogen (12); this conversion generally occurs 
during times of nutritional sufficiency (6). Muscle and liver are the main sites of glycogen 
storage (8, 12). In skeletal muscles, glycogen is broken down to produce ATP due to an energy 
demand; however, other tissues are supplied with glucose by the breakdown of liver glycogen 
(4). Liver glycogen is primarily used to maintain the glucose levels in the bloodstream (6, 7); it 
is also used to provide glucose to newborn mice until the liver is able to produce glucose by 
gluconeogenesis (7). Glycogen can also be made in other cells throughout the body (12). 
Glycogen synthesis is initiated by the self-glucosylation of glycogen in (4). The first 
enzyme in glycogen synthesis is glycogenin, which is responsible for catalyzing the first part of 
the glycogen chain from UDP-glucose (12). After initiation, glycogen synthase and branching 
enzyme continue the catalysis of glycogen synthesis; glycogen synthase elongates the chain, and 
branching enzyme transfers a chain of about 7 glucose molecules to a chain of about 11 
molecules (12, 4). The main linkage in glycogen is a-1,4-glycosidic link; however, the branch 
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points are introduced by a-I,6-glycosidic linkages (7, 9). There are two isofonns of glycogen 
synthase, GYS I and GYS2; GYS 1 is found in skeletal muscle, cardiac muscle, adipose tissue, 
kidney, lung, and brain cells, and GYS2 is only found in liver cells (12, 7). "Glycogen synthase 
activity is controlled by covalent modification, allosteric activation, and enzymatic translocation" 
(4). 
In the fetal rat lung, glycogen reaches a peak concentration in the last third of gestation; 
this is just before changes in glycogen synthase activity levels (5). There is a subsequent drop in 
glycogen concentration (3). This drop, at about 18 days postcoitum (dpc), is related to the 
appearance of lamellar bodies and an increase in phospholipid synthesis and concentration (2, 3, 
5). This had led to the belief that glycogen plays a role in the maturation of the developing lung 
(5). There are three roles that glycogen may play in the development of the lung: a source of 
precursors molecules in phospholipid synthesis; "as a source of reducing equivalents necessary 
for de novo fatty acid synthesis;" or an energy source (1). 
Lung surfactant is used to "reduce surface tension at the air liquid interface in the 
alveolus ofthe mature lung;" it is a lipoprotein complex with phosphatidylcholine being the 
primary lipid (1, 11). Data from Risdale and Post suggests that glycogen stores from type II lung 
cells in fetal mice are the site of surfactant phosphatidylcholine synthesis (11). The glycogen 
stores in lung cells are depleted as surfactant is synthesized; this may be because glycogen acts 
as a carbon source for making the glycerol backbone and acyl chains of the lipids (2, 11). 
Glycogen may also act as an energy source of phosphatidylcholine synthesis (11). 
In muscle, contractions are driven by glycogenolysis, the breakdown of glycogen-a 
phosphorolysis reaction that yields shortened glycogen and glucose-I-phosphate (4, 8, 12). 
Muscle glycogen can be manipulated by exercise and diet (8). While muscle glycogen may be 
important for human exercise, this may not be the case in rodents (8). In mice and rats, liver 
glycogen may be used for exercise; therefore, muscle glycogen is only limiting when liver 
glycogen is low (8). 
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In the present work, glycogen concentrations in the brain, heart, lung, liver, and muscle 
of wild-type fetal mice are compared from 14.5 to 18.5 dpc. This is the third trimester of 
gestation; typical mouse gestation lasts 21 days. The pattern of glycogen production and use can 
be related to the period oftime when organ tissues are developing in mice. 
Methods and Materials 
The mice used for this experiment were from the strain C57B1I6. All fetal glycogen 
concentrations were determined for wild-type mice. 
For timed pregnancies, female mice were introduced into a cage with male mice late in 
the afternoon. The following morning the females were checked for vaginal plugs. The mice 
were sacrificed by cervical dislocation from 14.5 days postcoitum to 18.5 days postcoitum. 
Then, the embryos were harvested, and tissues were collected into liquid nitrogen. The tissues 
were stored at -80°C until their glycogen content was determined. 
To determine glycogen content, powdered tissues samples from brain, muscle, liver, lung, 
or heart were boiled in 200 III 30% (w/v) KOH. The tissues were then cooled on ice and 65 III 
cold NaS04 was added followed by 540 III cold 100% ethanol. The samples were subsequently 
heated at 100°C for 2 minutes and then centrifuged for 20 minutes at 17,500 x g at 4°C. The 
supernatant was removed using a vacuum line and the pellet was then resuspended in 100 1I1 
water. For all tissues with the exception of brain, 200 III ethanol was added and then the 
samples were centrifuged as above. This glycogen precipitation step was then repeated and the 
pellet was dried in a Speed-Vac. 
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For brain tissues, after resuspension, 1 ml 4: 1 (v/v) methanol:cholorform was added and 
the samples were heated at 80°C for 5 minutes. The samples were centrifuged for 15 minutes at 
17,500 x g at 4°C. The supernatant was discarded, and the pellet resuspended in 100 III water. 1 
m14:1 (v/v) methanol:cholorform was added, then the samples were centrifuged as before. After 
removing the supernatant and resuspending the pellet in 100 III water, 200 III 100% ethanol was 
added. The samples were heated at 100°C for 2 minutes, then centrifuged at 17,500 x g for 20 
minutes at 4°C. After the supernatant was removed, the pellets were dried in a Speed-Vac. 
All glycogen pellets were then suspended in amyloglucosidase (0.3 mglml in 0.2 M 
NaOAc pH 4.8); pellets from brain were suspended in 100 Jll, all other tissues were suspended in 
200 Ill. The samples were then incubated at 40°C overnight to digest glycogen. To determine 
the concentration of glucose in the samples, 20 III digested glycogen (diluted in 0.2 M NaOAc, 
pH 4.8, where appropriate) was added to 180 III of a solution of 0.3 M triethanolamine, pH 7.5, 3 
mM MgS04, 11.2 mM ATP, 0.9 mM NADP, and 1JLglmi glucose-6-phosphate dehydrogenase. 
The absorbance was read at 340 nm before and after the addition of 5 III diluted hexokinase 
[stock hexokinase (1500 ulm1) was diluted 1:25 with 0.3 M triethanoiamine/3mM MgS04 pH 
7.5]. 
Results 
In the fetal brain, there is an increase in brain glycogen concentration at about 16.5 dpc. 
After this, glycogen concentration remained the same (Fig. 1); however, brain glycogen 
concentrations were consistently the lowest of any tissue. These fetal levels were higher than 
those we have measured in adult mouse brain (2-3 JLmol/g). 
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The fetal heart glycogen concentrations rose to a peak at 15.5 days, and then trended 
towards slightly lower levels that were maintained throughout development. The level of 
glycogen in the developing heart is as much as 50 fold higher than we have measured in mouse 
adult heart (about 1 JLmol/g). 
Starting out at glycogen concentrations of zero, fetal liver glycogen increased 
significantly at 15.5 dpc. By 18.5 dpc, the glycogen concentration in the liver was much higher 
than the peak concentration seen in other fetal tissues (Fig. 3).The level at 18.5 dpc is similar to 
what we measure in fed adult mouse liver. 
Muscle glycogen concentration has a large increase from 15.5 to 16.5 dpc, which remains 
steady through 18.5 dpc (Fig. 4). This glycogen level is 5-10 fold higher than what we measure 
in adult mouse muscle (5-10 pmoVg). 
In the fetal lung, glycogen concentration rose to a peak at about 17.5 dpc before falling to 
about halfthe level at the peak (Fig. 5). Aside from the liver, lung glycogen concentrations were 
the highest of the tissues. At the peak: of glycogen accumulation, the concentration of glycogen 
is as much as 60 fold higher than the level we measure in adult mouse lung (about 2 JLmollg). 
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Figure 1: Fetal brain glycogen concentrations from 14.5 to 18.5 days postcoitum. Glycogen 
content was determined for brain from wild type embryos as described in methods and materials. 
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Values are reported as means and standard errors of the mean (n=6). p=O.Ol when comparing 
values at 15.5 with values at 17.5 dpc. p=O.005 when comparing values at 15.5 with values at 
18.5 dpc. 
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Figure 2: Fetal heart glycogen concentrations from 14.5 to 18.5 days postcoitum. Glycogen 
content was determined for heart from wild type embryos as described in methods and materials. 
Values are reported as means and standard errors of the mean (n=5-7). p=O.03 when comparing 
values at 14.5 with values at 15.5 dpc. 
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Figure 3: Fetal liver glycogen concentrations from 14.5 to 18.5 days postcoitum. Glycogen 
content was determined for liver from wild type embryos as described in methods and materials. 
Values are reported as means and standard errors of the mean (n=4). p=O.OOOI when comparing 
values at 15.5 with values at 16.5 dpc. p=O.002 when comparing values at 16.5 with values at 
17.5 dpc. p=O.0002 when comparing values at 17.5 with values at 18.5 dpc. 
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Figure 4: Fetal muscle glycogen concentrations from 14.5 to 18.5 days postcoitum. 
Glycogen content was determined for muscle from wild type embryos as described in 
methods and materials. Values are reported as means and standard errors of the mean 
(n=3-4). p=O.002 when comparing values at 15.5 with values at 16.5 dpc. 
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Figure 5: Fetal lung glycogen concentrations from 14.5 to 18.5 days postcoitum. Glycogen 
content was determined for lung from wild type embryos as described in methods and materials. 
Values are reported as means and standard errors of the mean (n=3-4). p=O.OOI when comparing 
values at 15.5 with values at 16.5 dpc. p=O.04 when comparing values at 16.5 with values at 17.5 
dpc. p=O.07 when comparing values at 17.5 with values at 18.5 dpc. 
Discussion 
The results from these studies in mouse embryos are largely consistent with findings in 
rabbit reported by other investigations (14). 
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The brain showed very low levels of glycogen throughout the experiment. The role of 
glycogen in the brain is not well understood. Suggestions of its functions include maintaining 
neuron viability during ischemia and hypoglycemia and participation in memory fonnation. 
The liver is responsible for maintaining the glucose level of the bloodstream, which will 
provide glucose to the brain, as well as other tissues. After birth, before the liver begins 
gluconeogenesis, the liver is the main source of energy in the fonn of glucose (7); therefore, a 
large store must be built up while the fetus is still receiving nutrients from the mother. 
Pederson et al. observed that fetal mice lacking glycogen synthase had abnonnal heart 
morphology after about 14.5 dpc. This suggests that glycogen is needed for heart growth and 
development. This is also consistent with the peak in heart glycogen concentration at 15.5 dpc. 
The changes in mouse heart glycogen during development are not as dramatic as reported for 
rabbit. 
Muscle glycogen has been considered a major energy source for muscle contractions. 
Once the glycogen stores are exhausted, fatigue and impaired muscle perfonnance have been 
observed (8). Muscle contraction activates glycogen synthase (12); it has been observed that 
fetal mice begin to move at about day 14 after conception (13). The rise in muscle glycogen 
concentration seen from 14.5 to 16.5 dpc, may be due to the activation of glycogen synthase by 
motion. 
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The peak of glycogen concentration at about 17.5 dpc followed by a drop in 
concentration in the fetal lung confirms previous findings by Maniscalco et al. (5). This drop has 
also been linked to the appearance oflamellar bodies in the lung (2, 3, 5). Lamellar bodies are 
the storage sites of phospholipids produced in the lung; these phospholipids are used for the 
production oflung surfactant (5). Subsequent experiments could involve measuring the activity 
of glycogen synthase and glycogen phosphorylase to aid in understanding the regulation of 
glycogen accumulation in this and other tissues. Most importantly we would like to measure 
lung surfactant levels in 17.5 dpc embryos and compare the values with those obtained from 
embryos that are unable to synthesize lung glycogen. This would allow us to determine iflung 
glycogen is important for surfactant synthesis. 
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